SCHEMBL6235329

SCHEMBL6235329

ClCc1ccc(-c2cnc3nc(-c4cccs4)c(-c4cccs4)nc3c2)s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KB2 Q9UBS0 7/20 0.42
PDGFRB P09619 1/20 0.37
PDGFRA P16234 1/20 0.37
LTA4H P09960 1/20 0.36
CYP1A2 P05177 7/20 0.35
CASP1 P29466 7/20 0.35
CASP7 P55210 7/20 0.35
USP2 O75604 6/20 0.35
CYP3A4 P08684 6/20 0.35
ALDH1A1 P00352 6/20 0.35
CYP2C9 P11712 5/20 0.35
HSD17B10 Q99714 5/20 0.35
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
CYP2C19 P33261 3/20 0.35
RECQL P46063 1/20 0.35
DPP4 P27487 2/20 0.35
DHFR P00374 1/20 0.35
SRPK1 Q96SB4 1/20 0.34
HIF1A Q16665 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6233946 0.88 DPP4 (0.50) RPS6KB2PDGFRBPDGFRALTA4HCYP1A2
SCHEMBL6236374 0.84 RPS6KB2 (0.54) RPS6KB2PDGFRBPDGFRACYP1A2CASP1
SCHEMBL6257438 0.81 USP2 (0.44) RPS6KB2CYP1A2CASP1CASP7USP2
SCHEMBL6234678 0.79 DPP4 (0.50) RPS6KB2PDGFRBPDGFRACYP1A2CASP1
SCHEMBL6234523 0.77 CYP1A2 (0.42) RPS6KB2CYP1A2CASP1CASP7USP2
SCHEMBL6237105 0.76 RPS6KB2 (0.49) RPS6KB2PDGFRBPDGFRACYP1A2CASP1
SCHEMBL6233813 0.75 RPS6KB2 (0.43) RPS6KB2PDGFRBPDGFRACYP1A2CASP1
SCHEMBL6237798 0.74 RPS6KB2 (0.52) RPS6KB2PDGFRBPDGFRADHFRSRPK1
SCHEMBL6240032 0.74 RPS6KB2 (0.42) RPS6KB2PDGFRBPDGFRACYP1A2CASP1
SCHEMBL6236517 0.73 CYP2A6 (0.55) RPS6KB2PDGFRBPDGFRACASP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005007099-A2 PKB INHIBITORS AS ANTI-TUMOR AGENTS IMCLONE SYSTEMS INCORPORATED (US) 2005-01-27 WO disclosed